Black Rock Inc. Cure Vac N.V. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cure Vac N.V. stock. As of the latest transaction made, Black Rock Inc. holds 2,253,769 shares of CVAC stock, worth $6.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,253,769
Previous 1,974,954
14.12%
Holding current value
$6.2 Million
Previous $5.98 Million
28.04%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CVAC
# of Institutions
90Shares Held
12.1MCall Options Held
164KPut Options Held
117K-
Israel Englander Millennium Management LLC | New York, Ny2.42MShares$6.65 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$4.31 Million10.6% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.01MShares$2.78 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct780KShares$2.15 Million0.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL400KShares$1.1 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $516M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...